Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Cookson

Showing results (181-190 of 320) with videos related to

Pageof 32
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2021
THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomesDhananjay Yellajoshyula, Samuel S Pappas, Abigail E Rogers, et al.
Neurobiology of Disease|May 21, 2020
Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosisGeorge R Heaton, Natalie Landeck, Adamantios Mamais, et al.
Cells|October 27, 2020
Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse TissuesLucia Iannotta, Alice Biosa, Jillian H Kluss, et al.
Neuroscience Letters|June 16, 2005
Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) proteinRina Bandopadhyay, David W Miller, Ann E Kingsbury, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 8, 2023
Leucine-rich repeat kinase 2 limits dopamine D1 receptor signaling in striatum and biases against heavy persistent alcohol drinkingDaniel da Silva, Aya Matsui, Erin M Murray, et al.
Biochemical and Biophysical Research Communications|September 8, 2009
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sitesElisa Greggio, Jean-Marc Taymans, Eugene Yuejun Zhen, et al.
Journal of Neurochemistry|November 16, 2010
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutantVeronique Daniëls, Renée Vancraenenbroeck, Bernard M H Law, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2004
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localizationRosa M Canet-Avilés, Mark A Wilson, David W Miller, et al.
Annals of Clinical and Translational Neurology|November 3, 2021
Transcriptome analysis of collagen VI-related muscular dystrophy muscle biopsiesEleonora Guadagnin, Payam Mohassel, Kory R Johnson, et al.
Expert Opinion on Drug Discovery|March 14, 2013
Animal models for drug discovery in dystoniaHa Jinnah, Angelika Richter, Jonathon W Mink, et al.
Pageof 32

Showing results (181-190 of 320) with videos related to

Sort By:
Pageof 32
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2021
THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomesDhananjay Yellajoshyula, Samuel S Pappas, Abigail E Rogers, et al.
Neurobiology of Disease|May 21, 2020
Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosisGeorge R Heaton, Natalie Landeck, Adamantios Mamais, et al.
Cells|October 27, 2020
Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse TissuesLucia Iannotta, Alice Biosa, Jillian H Kluss, et al.
Neuroscience Letters|June 16, 2005
Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) proteinRina Bandopadhyay, David W Miller, Ann E Kingsbury, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 8, 2023
Leucine-rich repeat kinase 2 limits dopamine D1 receptor signaling in striatum and biases against heavy persistent alcohol drinkingDaniel da Silva, Aya Matsui, Erin M Murray, et al.
Biochemical and Biophysical Research Communications|September 8, 2009
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sitesElisa Greggio, Jean-Marc Taymans, Eugene Yuejun Zhen, et al.
Journal of Neurochemistry|November 16, 2010
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutantVeronique Daniëls, Renée Vancraenenbroeck, Bernard M H Law, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2004
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localizationRosa M Canet-Avilés, Mark A Wilson, David W Miller, et al.
Annals of Clinical and Translational Neurology|November 3, 2021
Transcriptome analysis of collagen VI-related muscular dystrophy muscle biopsiesEleonora Guadagnin, Payam Mohassel, Kory R Johnson, et al.
Expert Opinion on Drug Discovery|March 14, 2013
Animal models for drug discovery in dystoniaHa Jinnah, Angelika Richter, Jonathon W Mink, et al.
Pageof 32